Literature DB >> 11499402

Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia.

A A Farooqui1, L A Horrocks.   

Abstract

Plasmalogens are unique glycerophospholipids because they have an enol ether double bond at the sn-1 position of the glycerol backbone. They are found in all mammalian tissues, with ethanolamine plasmalogens 10-fold higher than choline plasmalogens except in muscles. The enol ether double bond at the sn-1 position makes plasmalogens more susceptible to oxidative stress than the corresponding ester-bonded glycerophospholipids. Plasmalogens are not only structural membrane components and a reservoir for second messengers but may also be involved in membrane fusion, ion transport, and cholesterol efflux. Plasmalogens may also act as antioxidants, thus protecting cells from oxidative stress. Receptor-mediated degradation of plasmalogens by plasmalogen-selective phospholipase A2 results in the generation of arachidonic acid, eicosanoids, and platelet activating factor. Low levels of these metabolites have trophic effects, but at high concentration they are cytotoxic and may be involved in allergic response, inflammation, and trauma. Levels of plasmalogens are decreased in several neurological disorders including Alzheimer's disease, ischemia, and spinal cord trauma. This may be due to the stimulation of plasmalogen-selective phospholipase A2. A deficiency of plasmalogens in peroxisomal disorders and Niemann-Pick type C disease indicates that this deficiency may be due to the decreased activity of plasmalogen synthesizing enzymes that occur in peroxisomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499402     DOI: 10.1177/107385840100700308

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  66 in total

1.  Abstracts of the 13th Meeting of the European Neurological Society. 14-18 June 2003, Istanbul, Turkey.

Authors: 
Journal:  J Neurol       Date:  2003-05       Impact factor: 4.849

Review 2.  Genetic diseases of the Kennedy pathways for membrane synthesis.

Authors:  Mahtab Tavasoli; Sarah Lahire; Taryn Reid; Maren Brodovsky; Christopher R McMaster
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

3.  Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis.

Authors:  Christopher J Stewart; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Zhaozhong Zhu; Liming Liang; Carlos A Camargo; Kohei Hasegawa
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

Review 4.  Studies on plasmalogen-selective phospholipase A2 in brain.

Authors:  Akhlaq A Farooqui
Journal:  Mol Neurobiol       Date:  2010-01-06       Impact factor: 5.590

5.  Discovering New Lipidomic Features Using Cell Type Specific Fluorophore Expression to Provide Spatial and Biological Specificity in a Multimodal Workflow with MALDI Imaging Mass Spectrometry.

Authors:  Marissa A Jones; Sung Hoon Cho; Nathan Heath Patterson; Raf Van de Plas; Jeffrey M Spraggins; Mark R Boothby; Richard M Caprioli
Journal:  Anal Chem       Date:  2020-05-06       Impact factor: 6.986

6.  Administration of myo-inositol plus ethanolamine elevates phosphatidylethanolamine plasmalogen in the rat cerebellum.

Authors:  Beth Hoffman-Kuczynski; Nicholas V Reo
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 7.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

8.  Differential effect of maternal diet supplementation with alpha-Linolenic adcid or n-3 long-chain polyunsaturated fatty acids on glial cell phosphatidylethanolamine and phosphatidylserine fatty acid profile in neonate rat brains.

Authors:  Frédéric Destaillats; Corinne Joffre; Niyazi Acar; Florent Joffre; Jean-Baptiste Bezelgues; Bruno Pasquis; Cristina Cruz-Hernandez; Serge Rezzi; Ivan Montoliu; Fabiola Dionisi; Lionel Bretillon
Journal:  Nutr Metab (Lond)       Date:  2010-01-14       Impact factor: 4.169

9.  Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid.

Authors:  Atsuko Kakio Kimura; Hee-Yong Kim
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

Review 10.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.